【摘要】：目的:檢測喉癌組織及細(xì)胞中miRNA-21的表達(dá)。構(gòu)建反義微小RNAhsa-miR-21慢病毒表達(dá)載體,觀察反義寡核苷酸重組慢病毒（ASO-miR-21）靶向調(diào)節(jié)Ras基因?qū)戆┘?xì)胞增殖、細(xì)胞周期、凋亡和抑制其侵襲的影響。 方法:應(yīng)用實時熒光定量PCR檢測喉癌組織及細(xì)胞中miRNA-21的表達(dá)。構(gòu)建反義hsa-miR-21慢病毒表達(dá)載體，體外轉(zhuǎn)染喉鱗癌Hep-2細(xì)胞，采用MTT法及克隆形成實驗檢測反義miR-21（ASO-miR-21）重組慢病毒對喉癌細(xì)胞的增殖能力；應(yīng)用流式細(xì)胞儀檢測喉鱗癌細(xì)胞細(xì)胞周期及凋亡情況。采用Boydenchambers法檢測喉鱗癌細(xì)胞的侵襲能力。采用免疫印跡法檢測RAS蛋白在喉鱗癌細(xì)胞中的表達(dá)。 結(jié)果:PCR檢測在喉癌組織與細(xì)胞中，miRNA-21表達(dá)顯著增高，并與臨床病理分期及分級相關(guān)。成功構(gòu)建反義hsa-miR-21的慢病毒表達(dá)載體，采用ASO-miR-21慢病毒抑制喉癌細(xì)胞內(nèi)高水平表達(dá)miR-21的活性后,可顯著抑制喉癌細(xì)胞增殖、誘導(dǎo)凋亡，及阻滯Hep-2細(xì)胞周期在G1期，并抑制其侵襲。Westernblot檢測轉(zhuǎn)染ASO-miR-21后的喉鱗癌細(xì)胞發(fā)現(xiàn)，Ras蛋白表達(dá)較對照組明顯減少。 結(jié)論:本研究發(fā)現(xiàn)喉癌組織與細(xì)胞中miRNA-21表達(dá)顯著增高，，轉(zhuǎn)染miR-21ASO可以明顯抑制喉癌細(xì)胞增殖、誘導(dǎo)凋亡，及阻滯Hep-2細(xì)胞周期在G1期，并抑制其侵襲。同時發(fā)現(xiàn)，miRNA-21能調(diào)節(jié)的Ras基因表達(dá)，參與其調(diào)控網(wǎng)絡(luò)。從而說明miR-21的發(fā)揮致癌作用，為喉癌及其他惡性腫瘤的基因治療提供的一個有效的靶標(biāo)和理論依據(jù)。
[Abstract]:Objective: to detect the expression of miRNA-21 in laryngeal carcinoma tissues and cells. The expression vector of antisense RNAhsa-miR-21 lentivirus was constructed, and the effects of Ras gene targeted regulation by antisense oligonucleotide recombinant lentivirus (ASO-miR-21) on the proliferation, cell cycle, apoptosis and inhibition of invasion of laryngeal carcinoma cells were observed. Methods: real-time fluorescence quantitative PCR was used to detect the expression of miRNA-21 in laryngeal carcinoma tissues and cells. The antisense hsa-miR-21 lentivirus expression vector was constructed and transfected into laryngeal squamous cell carcinoma (Hep-2) cells in vitro. The proliferation ability of antisense miR-21 (ASO-miR-21) recombinant lentivirus on laryngeal carcinoma cells was detected by MTT assay and clone formation assay. The cell cycle and apoptosis of laryngeal squamous cell carcinoma were detected by flow cytometry. The invasive ability of laryngeal squamous carcinoma cells was detected by Boydenchambers method. The expression of RAS protein in laryngeal squamous cell carcinoma cells was detected by Western blot. Results: the expression of miRNA-21 was significantly increased in laryngeal carcinoma tissues and cells by PCR, and correlated with clinicopathological stage and grade. The lentivirus expression vector of antisense hsa-miR-21 was successfully constructed. After ASO-miR-21 lentivirus inhibited the activity of high level expression of miR-21 in laryngeal carcinoma cells, it could significantly inhibit the proliferation and induce apoptosis of laryngeal carcinoma cells. Westernblot assay showed that the expression of Ras protein in laryngeal squamous carcinoma cells after ASO-miR-21 transfection was significantly lower than that in the control group. Conclusion: the expression of miRNA-21 was significantly increased in laryngeal carcinoma tissues and cells. Transfection of miR-21ASO could significantly inhibit the proliferation of laryngeal cancer cells, induce apoptosis, and block the cell cycle of Hep-2 in G1 phase and inhibit its invasion. At the same time, it was found that miRNA-21 can regulate the expression of Ras gene and participate in its regulatory network. Therefore, miR-21 can play a carcinogenic role and provide an effective target and theoretical basis for gene therapy of laryngeal cancer and other malignant tumors.
【學(xué)位授予單位】：哈爾濱醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2012
【分類號】：R739.65

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 方國強(qiáng);吳炳禮;李恩民;許麗艷;;miR-21與腫瘤[J];癌變.畸變.突變;2010年01期

2 朱普和;吳宗山;張立功;;鼻骨骨折的CT診斷價值及其對法醫(yī)鑒定的意義[J];安徽醫(yī)學(xué);2010年08期

3 黃學(xué)勤;程學(xué)仕;王俊芳;楊洋;;粉塵螨滴劑治療變應(yīng)性鼻炎的臨床療效及安全性觀察[J];安徽醫(yī)藥;2010年06期

4 范遲;高下;徐琳;朱光潔;陳杰;麻曉峰;丁小瓊;陸玲;周函;;攜帶神經(jīng)營養(yǎng)因子-3基因的重組腺病毒的構(gòu)建和鑒定[J];蚌埠醫(yī)學(xué)院學(xué)報;2010年01期

5 黃躍雁;楊杰;王宏梅;;鼻內(nèi)窺鏡下射頻治療老年頑固性鼻出血護(hù)理體會[J];承德醫(yī)學(xué)院學(xué)報;2010年03期

6 孟勝環(huán);李翠喬;馬金瑩;;甘桔冰梅片聯(lián)合穴位貼敷治療慢性咽炎療效觀察[J];重慶醫(yī)學(xué);2012年15期

7 沈平;劉彩霞;唐艷英;許平;胡賽紅;黎曉靜;;布地奈德氧氣霧化吸入治療嬰幼兒急性喉炎的效果觀察[J];當(dāng)代護(hù)士(中旬刊);2012年05期

8 汪志蘭;;鼻內(nèi)窺鏡下微波治療鼻出血的觀察與護(hù)理[J];當(dāng)代護(hù)士(�？瓢�);2009年04期

9 陳淑金;陳秀萍;洪桂娟;;急性會厭炎的護(hù)理[J];當(dāng)代護(hù)士(�？瓢�);2011年08期

10 朱秀琴;;綜合心理干預(yù)在懸雍垂腭咽成形術(shù)中的應(yīng)用[J];當(dāng)代護(hù)士(下旬刊);2012年04期

相關(guān)會議論文 前10條

1 廖月紅;;論和法治療變應(yīng)性鼻炎[A];中華中醫(yī)藥學(xué)會耳鼻喉科分會第15屆學(xué)術(shù)交流會論文集[C];2009年

2 顏文杰;夏紀(jì)嚴(yán);;EGFR及EGF在NPC中的作用及臨床意義[A];中華中醫(yī)藥學(xué)會耳鼻喉科分會第15屆學(xué)術(shù)交流會論文集[C];2009年

3 張治成;郭向東;李瑩;丁玲;楊曉;;鼻內(nèi)鏡下鼻腔淚囊吻合術(shù)35例臨床分析[A];中華中醫(yī)藥學(xué)會耳鼻喉科分會第15屆學(xué)術(shù)交流會論文集[C];2009年

4 錫林托婭;;蒙藥治療干燥性鼻炎60例[A];中華中醫(yī)藥學(xué)會耳鼻喉科分會第15屆學(xué)術(shù)交流會論文集[C];2009年

5 沈國勤;;血腑逐瘀湯加味治療聲帶小結(jié)96例臨床觀察[A];中華中醫(yī)藥學(xué)會耳鼻喉科分會第15屆學(xué)術(shù)交流會論文集[C];2009年

6 陳俏妍;夏紀(jì)嚴(yán);李云英;韓凌;彭桂原;孔U

本文編號：2398096